193 related articles for article (PubMed ID: 23166745)
1. Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats.
Rogala B; Li Y; Li S; Chen X; Kirouac GJ
PLoS One; 2012; 7(11):e49669. PubMed ID: 23166745
[TBL] [Abstract][Full Text] [Related]
2. Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests.
Huang P; Yakovleva T; Aldrich JV; Tunis J; Parry C; Liu-Chen LY
Neurosci Lett; 2016 Feb; 615():15-20. PubMed ID: 26780565
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.
Jamshidi RJ; Sullivan LC; Jacobs BA; Chavera TA; Berg KA; Clarke WP
J Pharmacol Exp Ther; 2016 Nov; 359(2):319-328. PubMed ID: 27605628
[TBL] [Abstract][Full Text] [Related]
4. Effect of norbinaltorphimine on ∆⁹-tetrahydrocannabinol (THC)-induced taste avoidance in adolescent and adult Sprague-Dawley rats.
Flax SM; Wakeford AG; Cheng K; Rice KC; Riley AL
Psychopharmacology (Berl); 2015 Sep; 232(17):3193-201. PubMed ID: 26025420
[TBL] [Abstract][Full Text] [Related]
5. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.
Bruchas MR; Land BB; Lemos JC; Chavkin C
PLoS One; 2009 Dec; 4(12):e8528. PubMed ID: 20052275
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
[TBL] [Abstract][Full Text] [Related]
7. Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats.
Chartoff E; Sawyer A; Rachlin A; Potter D; Pliakas A; Carlezon WA
Neuropharmacology; 2012 Jan; 62(1):167-76. PubMed ID: 21736885
[TBL] [Abstract][Full Text] [Related]
8. Ventral hippocampal kappa opioid receptors mediate the renewal of fear following extinction in the rat.
Cole S; Richardson R; McNally GP
PLoS One; 2013; 8(5):e58701. PubMed ID: 23675405
[TBL] [Abstract][Full Text] [Related]
9. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory.
Wall PM; Messier C
Psychopharmacology (Berl); 2002 Mar; 160(3):233-44. PubMed ID: 11889492
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
[TBL] [Abstract][Full Text] [Related]
11. Concurrent modulation of anxiety and memory.
Wall PM; Messier C
Behav Brain Res; 2000 May; 109(2):229-41. PubMed ID: 10762693
[TBL] [Abstract][Full Text] [Related]
12. κ opioid regulation of anxiety-like behavior during acute ethanol withdrawal.
Valdez GR; Harshberger E
Pharmacol Biochem Behav; 2012 Jul; 102(1):44-7. PubMed ID: 22487769
[TBL] [Abstract][Full Text] [Related]
13. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of the kappa opioid receptor attenuates THC-induced place aversions in adult male Sprague-Dawley rats.
Clasen MM; Flax SM; Hempel BJ; Cheng K; Rice KC; Riley AL
Pharmacol Biochem Behav; 2017 Dec; 163():30-35. PubMed ID: 29100992
[TBL] [Abstract][Full Text] [Related]
15. Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice.
Jackson KJ; Jackson A; Carroll FI; Damaj MI
Neuropharmacology; 2015 Oct; 97():270-4. PubMed ID: 26044637
[TBL] [Abstract][Full Text] [Related]
16. 14-3-3γ mediates the long-term inhibition of peripheral kappa opioid receptor antinociceptive signaling by norbinaltorphimine.
Wedemeyer MJ; Jennings EM; Smith HR; Chavera TS; Jamshidi RJ; Berg KA; Clarke WP
Neuropharmacology; 2022 Dec; 220():109251. PubMed ID: 36126728
[TBL] [Abstract][Full Text] [Related]
17. Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury.
Aceves M; Bancroft EA; Aceves AR; Hook MA
J Neurotrauma; 2017 Mar; 34(6):1164-1174. PubMed ID: 27736318
[TBL] [Abstract][Full Text] [Related]
18. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice.
Kamei J; Nagase H
Eur J Pharmacol; 2001 Apr; 418(1-2):141-5. PubMed ID: 11334876
[TBL] [Abstract][Full Text] [Related]
19. Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice.
Daumas S; Betourne A; Halley H; Wolfer DP; Lipp HP; Lassalle JM; Francés B
Neurobiol Learn Mem; 2007 Jul; 88(1):94-103. PubMed ID: 17374494
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]